SEP | SGM | UGD | UGE | SEGEN | UGO | Main Page

 

physiology, psychology and geneticsof obesity

 

Jack A. Yanovski, MD, PhD, Head, Unit on Growth and Obesity

Ning-Ping Feng, PhD, Postdoctoral Fellow

Jennifer McDuffie, PhD, Postdoctoral Fellow

Marian Tanofsky-Kraff, PhD, Postdoctoral Fellow

Lisa Yanoff, MD, Postdoctoral Fellow

Renee Freedman, MD, Clinical Fellow, Endocrine Training Program

Cong Ning, MD, PhD, Clinical Fellow, Endocrine Training Program

Diane Adler-Wailes, MS, Scientific Technician

Deborah Glasofer, BA, Graduate Student

Samareh Ghorbani, BS, Postbaccalaureate Fellow

Margaret Mirch, BS, Postbaccalaureate Fellow

Amanda Spitalnik, BS, Postbaccalaureate Fellow

Kelly Theim, BA, Postbaccalaureate Fellow

Anne-Caroline Norman, BA, Clinical Research Training Program

Nazrat Mirza, MD, Volunteer      

Elena Puricelli, MD, Volunteer

 

The prevalence of overweight and obesity in children and adults has tripled during the past 30 years. The alarming rise in body weight has likely occurred because the current environment affords easy access to calorie-dense foods and requires less voluntary energy expenditure. However, today’s environment leads to obesity only in those individuals whose body weight–regulatory systems are not able to control body adiposity with sufficient precision in our high-calorie/low-activity environment, suggesting that subgroups in the United States have a uniquely high susceptibility to weight gain under the prevailing environmental conditions. Our research is directed at increasing our understanding of the metabolic and behavioral factors involved in determining body weight regulation and body composition during childhood, with a special emphasis on minority populations. The ongoing research program prospectively evaluates risk factors for the development of obesity and its complications in children, studies the effects of medications on body weight and obesity-related comorbid conditions in children, and seeks to identify the genetic and environmental factors important for the markedly greater incidence of obesity and its comorbid conditions in some U.S. minority populations.

Molecular studies of factors important for childhood body weight regulation

Feng, Adler-Wailes, Ning, Puricelli, Tanofsky-Kraff, Glasofer, Yanovski J

Using classical association studies, we are studying polymorphisms in genes involved in the leptin signaling pathway. Our goal is to identify gene variants affecting body composition, genes whose frequencies in African American children differ from those in their Caucasian counterparts. Genes currently under study include those encoding proopiomelanocortin (POMC), POMC processing enzymes, the melanocortin receptors 3, 4, and 5, and neuropeptide Y and its receptors. In addition, we have studied genes important for energy expenditure, such as those encoding the mitochondrial uncoupling proteins, and genes potentially involved in cortisol metabolism that may affect intra-abdominal adipose tissue, such as that encoding 11-beta-hydroxysteroid dehydrogenase. We have found that an intronic polymorphism in the 11-beta-hydroxysteroid dehydrogenase gene is associated with several features of metabolic syndrome in children. We have also identified novel polymorphisms in the POMC sequence that are more prevalent in African American than Caucasian children but do not appear to play a role in the greater body adiposity of African American children.

We are currently studying a variant melanocortin 3 receptor that is associated with adiposity in a large cohort of children and appears to have functional significance for melanocortin 3 receptor signal transduction. We directly sequenced the human MC3R proximal promoter region and the entire coding region in 88 children, of whom 47 were extremely overweight (BMI 41.8 ±10.5 kg/m2) and 41 were lean (BMI 16.8 ± 2.2 kg/m2). By sequencing, we found two previously identified missense sequence variants: C17A (Thr6Lys) and G241A (Val81Ile). Thr6Lys was located in the N-terminal extracellular domain where it might disrupt a putative site of post-translational phosphorylation by the serine/threonine kinase casein kinase II; Val81Ile was located in the first transmembrane helix. Of 282 children studied by RFLP analysis, 45 percent carried at least one of the mutant alleles. The two variants showed marked linkage disequilibrium. Therefore, we characterized the genotypes based on the combination of the two variants. African American children were more likely to carry the variant alleles than Caucasian children: 70.3 percent of African Americans (versus 19.9 percent of Caucasians) carried at least one mutant allele, and 15.3 percent of African Americans (versus 1.4 percent of Caucasians) were homozygous for both polymorphisms. Overweight children evidenced higher frequencies of the variants than normal-weight children. Children homozygous for both variants were identified only among children at risk for becoming overweight (9.7 percent) or already overweight (13.9 percent). Compared with unaffected or heterozygous children, those homozygous for both MC3R alleles exhibited significantly greater BMI-SD score, fat mass, and body circumference measurements and higher plasma levels of insulin and leptin. Analysis by race showed greater BMI-SD score and DXA body fat mass for both African American and Caucasian children homozygous for both variants of the two MC3R loci.

To study the functional consequences of these MC3R missense variants, we transiently expressed both singly and doubly variant MC3R receptors in HEK293 cells and compared ligand affinity and cAMP generation with that of the wild-type receptor. Saturation curves for binding of 125I-NDP alpha-MSH showed that the doubly mutant Thr6Lys and Val81Ile MC3R bound approximately 60 percent less 125I-NDP alpha-MSH than the wild-type receptor. A Scatchard analysis showed that the Kd for the singly or doubly variant MC3R did not differ significantly from the wild type. However, the level of surface expression, as reflected by the estimated maximum binding (Bmax), was significantly lower for the doubly mutant MC3R (56.9pM) than for the wild-type MC3R (137.7pM). The decreased maximum binding without an affinity change suggests that the doubly mutant receptor has fewer available alpha-MSH binding sites.

By examining coupling to adenylyl cyclase upon stimulation by NDP alpha-MSH in transiently transfected HEK293 cells, we then measured the functional activity of the mutants. The Val81Ile+Thr6Lys double mutant MC3R had significantly lower maximal intracellular cAMP generation than wild-type MC3R. We also studied the functional activity of the mutant MC3R in LVIP2.0Zc cells stably transfected with a cAMP-responsive beta-galactosidase reporter gene. Upon stimulation by NDP alpha-MSH, the doubly mutant MC3R produced significantly less maximal beta-galactosidase activity without change in EC50, paralleling the changes in intracellular cAMP accumulation. To study translational efficiency, we transiently expressed MC3R-GFP fusion proteins in LVIP2.0Zc cells, finding decreased protein expression. In sum, we found that the co-occurrence of two previously identified variants was associated with impaired cAMP generation in vitro and with greater BMI-SD, greater body fat mass, and higher plasma insulin and leptin levels, both in African American and Caucasian children. Our findings represent the first report of a significant relationship between these variants and pediatric obesity. Homozygocity for the MC3R double mutant may contribute to the greater prevalence of overweight in African Americans. Ongoing studies focus on understanding the mechanisms by which these sequence alterations may affect body weight.

Feng NP, Adler-Wailes D, Elberg J, Chin J, Fallon E, Carr A, Fraser del Llado T, Yanovski JA. Sequence variants of the proopiomelanocortin (POMC) gene and their associations with body composition in lean and overweight children. Obes Res 2003;11:619-624.

Gelernter-Yaniv LG, Feng NP, Sebring NG, Hochberg Z, Yanovski JA. Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition. Int J Obes 2003;27:983-986.

Physiology, metabolism, and psychology of childhood body weight regulation

McDuffie, Tanofsky-Kraff, Norman, Yanovski J; in collaboration with Keil, Schoeller, Warden, Yanovski S, Young-Hyman

Our studies are directed at understanding the physiological, psychological, and metabolic factors that identify children at risk for undue weight gain. As part of these studies, we have examined how best to measure psychopathology, insulin sensitivity, and changes in body composition. We found a noninvasive air displacement plethysmographic approach that is highly correlated with results from dual energy X-ray absorptiometry. In recent studies, we found that the hyperglycemic clamp procedure was highly correlated with the more technically demanding euglycemic, hyperinsulinemic clamp study in children and suitable for assessing insulin sensitivity in children. We then found that African American children have greater insulin secretion, a greater prevalence of acanthosis nigricans, and less insulin sensitivity than Caucasian children of similar body composition. The results imply that the relationships between visceral fat and complications of obesity differ in African Americans and Caucasians. The susceptibility to weight gain in African Americans may also result from differences in metabolic efficiency. We also found that resting energy expenditure is approximately 90 kcal/d less in African American than in Caucasian normal-weight and overweight boys and girls. Our studies suggest that the differences are not explained by differences in the hormone leptin. We also studied the effects of adiposity on skeletal maturation in African American and Caucasian children, finding that a substantial portion of the advancement of sexual and skeletal maturation observed in African American children may be explained by their greater adiposity. Studies concentrating on binge eating behaviors in children suggest that such behaviors also are associated with adiposity in children, and ongoing investigations suggest that binge-eating behavior may predict future weight gain in children at risk for becoming overweight.

To determine the factors that are most important for development of the complications of obesity in African American and Caucasian youth, we are involved in two ongoing protocols to study normal-weight African American and Caucasian children and adolescents, already obese African American and Caucasian children, and nonobese African American and Caucasian children of obese parents. We are assessing body composition, metabolic rate, insulin sensitivity, glucose disposal, and genetic factors believed to regulate metabolic rate, such as the uncoupling proteins, leptin and its receptor, and the beta-3 adrenergic receptor. We are also studying psychological and behavioral factors, such as propensity to engage in binge-eating behavior. We have recently found that children who report binge eating during childhood have greater adiposity than those not reporting such behavior. These children are being studied longitudinally into adulthood. We hypothesize that differences in the above-mentioned factors predict the development of obesity and may be of great importance in developing rational approaches for the prevention and treatment of obesity in the diverse U.S. population.

Elberg J, McDuffie JR, Sebring NG, Salaita C, Keil M, Robotham D, Reynolds JC, Yanovski JA. Comparison of methods to assess change in children’s body composition. Am J Clin Nutr 2004;80:64-69.

Field AE, Laird N, Steinberg E, Fallon E, Semega-Janneh M, Yanovski JA. Which metric of relative weight best captures body fatness in children? Obes Res 2003;11:1345-1352.

Tanofsky-Kraff M, Morgan CM, Yanovski SZ, Marmarosh C, Wilfley DE, Yanovski JA. Comparison of assessments of children’s eating disordered behaviors by interview and questionnaire. Int J Eat Disord 2003;33:213-224.

Tanofsky-Kraff M, Yanovski SZ, Wilfley DE, Marmarosh C, Morgan CM, Yanovski JA. Eating disordered behaviors, body fat, and psychopathology in overweight and normal weight children. J Consult Clin Psychol 2004;72:53-61.

Uwaifo GI, Nguyen TT, Russell DL, Keil MF, Nicholson JC, Bonat SH, McDuffie JR, Yanovski JA. Differences in insulin secretion and sensitivity of Caucasian and African American prepubertal children. J Pediatr 2002;140:673-680.

Treatment of children and adolescents with comorbid conditions associated with obesity

McDuffie, Uwaifo, Cohen,a Fallon,b Freedman, Parikh,c Tanofsky-Kraff, Yanovski J; in collaboration with Calis, Drinkard, Krakoff, Reynolds, Riggs, Rolls, Semega-Janneh, Sebring, Salaita, Young-Hyman,

Given the rapid increase in the prevalence of obesity, the development of treatments for obesity in childhood is urgently needed. In two ongoing clinical protocols, we are studying novel approaches to the control of body weight in children. We have completed a pilot study demonstrating that severely overweight adolescents can lose weight when enrolled in a comprehensive weight management program that includes the novel gastrointestinal lipase inhibitor orlistat as an adjunct to a behavior modification program. We have also found evidence that one mechanism through which orlistat may affect body weight is by changing the hedonic value of dietary fat. A placebo-controlled randomized trial will determine whether the use of orlistat improves weight loss of African American and Caucasian children and adolescents with obesity-related comorbidities. A second study examines the mechanism by which metformin, another novel weight loss agent, may affect the body weight of younger children with hyperinsulinemia.

Heck AM, McDuffie J, Carobene SE, Calis K, Yanovski JA. Additive gastrointestinal effects with concomitant use of olestra and orlistat. Ann Pharmacother 2002;36:1003-1005.

McDuffie JR, Calis KA, Booth S, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002;22:814-822.

McDuffie JR, Calis KA, Uwaifo GI, Freedman RJ, Sebring NG, Fallon EM, Frazer TE, Hubbard VS, Yanovski JA. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab 2004;17:307-319.

Yanovski JA, Yanovski SZ. Treatment of pediatric and adolescent obesity. JAMA 2003;289:1851-1852.

Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 2002;346:591-602.

Environmental factors affecting adult weight gain

Yanovski J, Yanoff; in collaboration with Yanovski S

We are also interested in assessing the impact of the environment on body weight gain. To determine the role of seasonal variation in weight change, we prospectively studied 200 U.S. adults, following them longitudinally. We found that the only time during which weight changes significantly is during the fall-winter holiday season between Thanksgiving and New Year’s Day. Such studies have implications for individuals attempting to control their weight. We have also studied the impact of chemotherapy on weight gain in women with breast cancer, finding that redistribution of body mass from lean tissues to fat mass occurs during the first year after such chemotherapy and that development of estrogen deficiency attributable to chemotherapy is also a risk factor for weight change in such women.

We are also interested in the role of dietary calcium in determining body weight change. A new protocol is designed to examine the impact of dietary calcium supplementation on body weight in a randomized, controlled trial of 340 adults. One hypothesis for how calcium intake may affect body adiposity points to alteration of plasma concentrations of calcitropic hormones such as 1,25 dihydroxy vitamin D. 1,25 dihydroxy vitamin D has been found in vitro to stimulate lipogenesis. Others have hypothesized that deficient calcium intake stimulates parathyroid hormone and promotes conversion of 25 hydroxy vitamin D to 1,25 dihydroxy vitamin D, thereby stimulating lipogenesis and leading to greater body weight in humans. We have determined that 1,25 dihydroxy vitamin D concentrations are not increased in overweight and obese adults; rather, we observed vitamin D deficiency (and lower 1,25 dihydroxy vitamin D concentrations) among severely obese adults. The ongoing randomized controlled trial will answer important questions about the value of calcium supplementation for the prevention of future weight gain.

Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, Sebring N, Reynolds JC, Yanovski JA. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab 2004;88:2248-2253.

Leser M, Yanovski SZ, Yanovski JA. Low fat intake and greater activity level are associated with lower weight regain 3 years after completing a very-low-calorie diet. J Amer Dietetic Assoc 2002;102:1252-1256.

Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA. The relationship between obesity and serum 1, 25 dihydroxy vitamin D concentrations in healthy adults. J Clin Endo Metab 2004;89:1196-1199.

Parikh SJ, Yanovski JA. Calcium intake and adiposity. Am J Clin Nutr 2003;77:281-287.

aMarc Cohen, MD, former Medical Student

bErica Fallon, MS, former Predoctoral Fellow

cShamik Parikh, MD, former Clinical Fellow

COLLABORATORS

Greti Aguilera, MD, Developmental Endocrinology Branch, NICHD, Bethesda, MD

Silva Arslanian, MD, Pittsburgh Children’s Hospital, Pittsburgh, PA

Sarah Booth, PhD, Tufts University, Boston, MA

Karim Calis, DPharm, Pharmacy Department, Warren Grant Magnuson Clinical Center, NIH, Bethesda, MD

Bart Drinkard, PT, Rehabilitation Medicine Department, Warren Grant Magnuson Clinical Center, NIH, Bethesda, MD

Leonard H. Epstein, PhD, State University of New York, Buffalo, NY

Alison Field, DSc, Brigham and Women’s Hospital, Boston, MA

Zeev Hochberg, MD, Rambam Children’s Hospital, Haifa, Israel

Margaret Keil, RN, PNP, Developmental Endocrinology Branch, NICHD, Bethesda, MD

Jonathan Krakoff, MD, Clinical Diabetes and Nutrition Section/Phoenix Epidemiology and Clinical Research Branch, NIDDK, Phoenix, AZ

Rudolph L. Leibel, MD, Columbia University College of Physicians and Surgeons, New York, NY

Constantine Londos, DDS, PhD, Laboratory of Cellular and Developmental Biology, NIDDK, Bethesda, MD

James D. Malley, PhD, Mathematical and Statistical Computing Laboratory, CIT, Bethesda, MD

Vincent Manganiello, MD, Pulmonary Critical Care Medicine Branch, NHLBI, Bethesda, MD

James Reynolds, MD, Nuclear Medicine, Warren Grant Magnuson Clinical Center, NIH, Bethesda, MD

Patti Riggs, RD, Nutrition Department, Warren Grant Magnuson Clinical Center, NIH, Bethesda, MD

Barbara Rolls, PhD, Pennsylvania State University, University Park, PA

Christine Salaita, MS, RD, Nutrition Department, Warren Grant Magnuson Clinical, NIH, Bethesda, MD

Dale Schoeller, PhD, University of Wisconsin, Madison, WI

Nancy Sebring, MEd, RD, Nutrition Department, Warren Grant Magnuson Clinical Center, NIH, Bethesda, MD

Craig Warden, PhD, University of California, Davis, CA

Denise E. Wilfley, PhD, Washington University School of Medicine, St. Louis, MO

Susan Z. Yanovski, MD, Obesity and Eating Disorders Program, NIDDK, Bethesda, MD

Debra Young-Hyman, PhD, Risk, Prevention, and Health Behavior Integrated Review Group, Center for Scientific Review, NIH, Rockville, MD

For further information, contact yanovskj@mail.nih.gov